Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Seres Therapeutics Inc. Stock Is Tanking Today

TheMotleyFool

0 0

Why Seres Therapeutics Inc. Stock Is Tanking Today

Shares of Seres Therapeutics (NASDAQ: MCRB), a clinical-stage biotech focused on microbiome therapeutics, were down 19% as of 11:25 a.m. EDT on Monday. The decline can be traced to the release of less-than-stellar news from a phase 1 clinical trial.

Seres reported top-line results from a phase 1b study today. This study was evaluating its compound SER-287 as a hopeful treatment for ulcerative colitis.

Here are the key headlines from the study that management is trying to get investors to focus on:

Source: Fool.com